Contemporary Baseline Clinical Profile of Chronic Hypertensive Heart Failure in Ibadan, Nigeria

O S Ogah1,2, O A Orimolade1, A A Adebiyi1,2

  • 1Cardiology Unit, Department of Medicine, University College Hospital, Ibadan, Ibadan, Oyo State, Nigeria.

PubMed

Insights

Hypertensive heart disease in Nigeria affects a younger population than in high-income countries. Early hypertension prevention is crucial to reduce cardiovascular disease burden in Sub-Saharan Africa.

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Background:

  • Cardiovascular disease (CVD) is a leading cause of death in Sub-Saharan Africa (SSA).
  • Data on hypertensive heart disease patterns in SSA is limited.
  • Hypertensive heart disease poses a significant health challenge in the region.

Purpose of the Study:

  • To describe the characteristics of heart failure due to hypertensive heart disease in Ibadan, Nigeria.
  • To provide insights into the demographics and clinical features of this condition in the Nigerian population.

Main Methods:

  • A hospital-based cross-sectional study was conducted at the University College Hospital, Ibadan, Nigeria.
  • Data was collected from 753 patients with chronic hypertensive heart failure between August 2016 and July 2021.
  • Statistical analysis was performed using SPSS, with a significance level of p < 0.05.

Main Results:

  • The study included 753 subjects with a mean age of 60.3 years.
  • Diabetes mellitus was the most common comorbidity (13.9%).
  • Females had higher serum sodium, creatinine, and total cholesterol. Males were more prone to left-axis deviation, left atrial abnormality, and heart failure with reduced ejection fraction.

Conclusions:

  • Hypertensive heart failure in Ibadan affects a younger demographic compared to high-income countries.
  • Findings align with existing data from other SSA regions.
  • Emphasizes the need for widespread hypertension preventive programs to mitigate cardiovascular disease.
Abstract

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
471
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
323
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.0K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
710
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
511
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
803